These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1642 related articles for article (PubMed ID: 31477562)

  • 1. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment.
    Nagpal R; Neth BJ; Wang S; Craft S; Yadav H
    EBioMedicine; 2019 Sep; 47():529-542. PubMed ID: 31477562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut mycobiome and its interaction with diet, gut bacteria and alzheimer's disease markers in subjects with mild cognitive impairment: A pilot study.
    Nagpal R; Neth BJ; Wang S; Mishra SP; Craft S; Yadav H
    EBioMedicine; 2020 Sep; 59():102950. PubMed ID: 32861197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study.
    Neth BJ; Mintz A; Whitlow C; Jung Y; Solingapuram Sai K; Register TC; Kellar D; Lockhart SN; Hoscheidt S; Maldjian J; Heslegrave AJ; Blennow K; Cunnane SC; Castellano CA; Zetterberg H; Craft S
    Neurobiol Aging; 2020 Feb; 86():54-63. PubMed ID: 31757576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a ketogenic and low-fat diet on the human metabolome, microbiome, and foodome in adults at risk for Alzheimer's disease.
    Dilmore AH; Martino C; Neth BJ; West KA; Zemlin J; Rahman G; Panitchpakdi M; Meehan MJ; Weldon KC; Blach C; Schimmel L; Kaddurah-Daouk R; Dorrestein PC; Knight R; Craft S;
    Alzheimers Dement; 2023 Nov; 19(11):4805-4816. PubMed ID: 37017243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota Composition Is Related to AD Pathology.
    Verhaar BJH; Hendriksen HMA; de Leeuw FA; Doorduijn AS; van Leeuwenstijn M; Teunissen CE; Barkhof F; Scheltens P; Kraaij R; van Duijn CM; Nieuwdorp M; Muller M; van der Flier WM
    Front Immunol; 2021; 12():794519. PubMed ID: 35173707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between Diet, the Gut Microbiome, and Short-Chain Fatty Acid Production among Older Caribbean Latino Adults.
    Maldonado-Contreras A; Noel SE; Ward DV; Velez M; Mangano KM
    J Acad Nutr Diet; 2020 Dec; 120(12):2047-2060.e6. PubMed ID: 32798072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and CSF metabolomics analysis shows Mediterranean Ketogenic Diet mitigates risk factors of Alzheimer's disease.
    Schweickart A; Batra R; Neth BJ; Martino C; Shenhav L; Zhang AR; Shi P; Karu N; Huynh K; Meikle PJ; Schimmel L; Dilmore AH; Blennow K; Zetterberg H; Blach C; Dorrestein PC; Knight R; ; Craft S; Kaddurah-Daouk R; Krumsiek J
    NPJ Metab Health Dis; 2024; 2(1):15. PubMed ID: 38962750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Modified Mediterranean Ketogenic Diet mitigates modifiable risk factors of Alzheimer's Disease: a serum and CSF-based metabolic analysis.
    Schweickart A; Batra R; Neth BJ; Martino C; Shenhav L; Zhang AR; Shi P; Karu N; Huynh K; Meikle PJ; Schimmel L; Dilmore AH; Blennow K; Zetterberg H; Blach C; Dorrestein PC; Knight R; ; Craft S; Kaddurah-Daouk R; Krumsiek J
    medRxiv; 2023 Nov; ():. PubMed ID: 38076824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease.
    Marizzoni M; Cattaneo A; Mirabelli P; Festari C; Lopizzo N; Nicolosi V; Mombelli E; Mazzelli M; Luongo D; Naviglio D; Coppola L; Salvatore M; Frisoni GB
    J Alzheimers Dis; 2020; 78(2):683-697. PubMed ID: 33074224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.
    Gangishetti U; Christina Howell J; Perrin RJ; Louneva N; Watts KD; Kollhoff A; Grossman M; Wolk DA; Shaw LM; Morris JC; Trojanowski JQ; Fagan AM; Arnold SE; Hu WT
    Alzheimers Res Ther; 2018 Sep; 10(1):98. PubMed ID: 30253800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Gut Microbial Metabolites in Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Signals in Host-Microbe Interplay.
    Wu L; Han Y; Zheng Z; Peng G; Liu P; Yue S; Zhu S; Chen J; Lv H; Shao L; Sheng Y; Wang Y; Li L; Li L; Wang B
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33466861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet-Microbiota-Brain Axis in Alzheimer's Disease.
    Kincaid HJ; Nagpal R; Yadav H
    Ann Nutr Metab; 2021; 77 Suppl 2(Suppl 2):21-27. PubMed ID: 33906194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between personality traits and cerebrospinal fluid biomarkers of Alzheimer's disease pathology modulates cognitive performance.
    Tautvydaitė D; Kukreja D; Antonietti JP; Henry H; von Gunten A; Popp J
    Alzheimers Res Ther; 2017 Feb; 9(1):6. PubMed ID: 28153054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small extracellular vesicles in plasma reveal molecular effects of modified Mediterranean-ketogenic diet in participants with mild cognitive impairment.
    Kumar A; Sharma M; Su Y; Singh S; Hsu FC; Neth BJ; Register TC; Blennow K; Zetterberg H; Craft S; Deep G
    Brain Commun; 2022; 4(6):fcac262. PubMed ID: 36337342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Microbiota-Gut-Brain Axis in Alzheimer's Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions.
    Murray ER; Kemp M; Nguyen TT
    Arch Clin Neuropsychol; 2022 Feb; 37(3):595-607. PubMed ID: 35202456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketogenic diet rescues cognition in ApoE4+ patient with mild Alzheimer's disease: A case study.
    Morrill SJ; Gibas KJ
    Diabetes Metab Syndr; 2019; 13(2):1187-1191. PubMed ID: 31336463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of gut microbiota and plasma amyloid-β as a potential index for identifying preclinical Alzheimer's disease: a cross-sectional analysis from the SILCODE study.
    Sheng C; Yang K; He B; Du W; Cai Y; Han Y
    Alzheimers Res Ther; 2022 Feb; 14(1):35. PubMed ID: 35164860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary Fiber Modulates the Release of Gut Bacterial Products Preventing Cognitive Decline in an Alzheimer's Mouse Model.
    Cuervo-Zanatta D; Syeda T; Sánchez-Valle V; Irene-Fierro M; Torres-Aguilar P; Torres-Ramos MA; Shibayama-Salas M; Silva-Olivares A; Noriega LG; Torres N; Tovar AR; Ruminot I; Barros LF; García-Mena J; Perez-Cruz C
    Cell Mol Neurobiol; 2023 May; 43(4):1595-1618. PubMed ID: 35953741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 83.